menu
    • menu

    Company profile for Micreos Human Health

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Micreos develops the world's first targeted antibacterial products, set to replace antibiotics. The company is viewed as global leader spearheading this exciting new field. With Micreos endolysin technology, for the first time we can kill only the unwanted bacteria - including antibiotic resistant strains - while preserving the beneficial bacteria, essential for our health. In addition, scientists do not expect emergence of re...
    Micreos develops the world's first targeted antibacterial products, set to replace antibiotics. The company is viewed as global leader spearheading this exciting new field. With Micreos endolysin technology, for the first time we can kill only the unwanted bacteria - including antibiotic resistant strains - while preserving the beneficial bacteria, essential for our health. In addition, scientists do not expect emergence of resistance against endolysins, based on their working mechanism.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Micreos Human HealthNetherlands1 Flag
    Country
    Country
    Netherlands
    Address
    Address
    A. van Leeuwenhoeklaan 9 Gebouw SR 3721 MA Bilthoven
    Telephone
    Telephone
    +31 (0) 88 800 7100
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.micreos.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Micreos’ Alternative to Antibiotics Secures Next €25 Million
    Micreos’ Alternative to Antibiotics Secures Next €25 Million

    25 Oct 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20221025005513/en

    BUSINESSWIRE
    25 Oct 2022
    Share Share
    Micreos Pharma Welcomes Trine Ahlgreen and Carsten Edwards to Its Executive Team
    Micreos Pharma Welcomes Trine Ahlgreen and Carsten Edwards to Its Executive Team

    05 Apr 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220405005632/en

    BUSINESSWIRE
    05 Apr 2022
    Share Share
    Micreos appoints Matt Regan as CEO of its Pharmaceutical business
    Micreos appoints Matt Regan as CEO of its Pharmaceutical business

    14 Oct 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/micreos-appoints-matt-regan-as-ceo-of-its-pharmaceutical-business-301399820.html

    PRNEWSWIRE
    14 Oct 2021
    Share Share
    Micreos lands $37M to show whether antibiotic alternative works
    Micreos lands $37M to show whether antibiotic alternative works

    01 Oct 2021

    // Nick Paul Taylor FIERCEBIOTECH

    https://www.fiercebiotech.com/biotech/micreos-lands-37m-to-show-if-antibiotic-alternative-delivers-clinic

    Nick Paul Taylor FIERCEBIOTECH
    01 Oct 2021
    Share Share
    Micreos secures €32 million for its endolysin-based platform as sustainable alternative to antibiotics
    Micreos secures €32 million for its endolysin-based platform as sustainable alternative to antibiotics

    30 Sep 2021

    // PRESS RELEASE

    https://www.micreos.com/news/Micreos-secures-32-million-for-its-endolysin-based-platform-as-sustainable-alternative-to-antibiotics.aspx

    PRESS RELEASE
    30 Sep 2021
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search